Merck & Co., Inc. (MRK) financials

Merck & Co., Inc. (MRK) revenue, EBIT and EBITDA, earnings per share, free cash flow, margins, debt and shareholders equity — annual and quarterly history, charted from SEC filings. No account needed.

In fiscal 2025, Merck & Co., Inc. reported revenue of $65.01B, up 1.3% year over year, net income of $18.25B, diluted EPS of $7.28 and free cash flow of $12.36B.

Revenue (fiscal 2025)

$65.01B

Revenue growth (fiscal 2025)

1.3%

Net income (fiscal 2025)

$18.25B

Diluted EPS (fiscal 2025)

$7.28

Free cash flow (fiscal 2025)

$12.36B

Merck & Co., Inc. files with the U.S. Securities and Exchange Commission under CIK 0000310158, classified as Pharmaceutical Preparations.

Explore annual and quarterly revenue, earnings, cash flow, margins, debt and equity from SEC filings.